Nuclear Diamond Batteries, Inc. (OTC: NDBI) Summarizes Expanding U.S. Patent Portfolio and Near-Term Intellectual Property Strategy for Nuclear Diamond Battery Platform

NDBI secures three U.S. patent allowances but remains pre-revenue and pre-commercial.

What the company is saying

Nuclear Diamond Batteries, Inc. announces three Notices of Allowance from the USPTO as of July 2026, positioning these as foundational intellectual property milestones for its nuclear diamond battery architecture. The company frames these patents as covering core technologies, including a nuclear voltaic power source, a high-porosity MOF electrode with carbon nano-onion structures, and proprietary carbon nano-onion synthesis methods. Management emphasizes the breadth of its pending applications and signals intent to expand both the geographic and technical scope of its IP portfolio. The narrative highlights potential applications in defense, aerospace, medical, industrial, and IoT sectors, but does not reference any commercial partners, contracts, or revenue. The tone is neutral and factual on patent progress, but aspirational regarding future market impact. The announcement explicitly states that the company is still in the development stage and has not started commercial production.

What the data suggests

The only concrete data disclosed are the three USPTO patent allowances: U.S. Patent No. 12,394,534 B2 (from Application No. 17/926,508), a May 2026 Notice of Allowance for Application No. 17/928,967 (19 claims), and a July 7, 2026 Notice of Allowance for Application No. 18/015,242 (18 claims). No financial, operational, or commercial metrics are provided. The company confirms it has not commenced commercial production, and there are no figures for revenue, expenses, cash flow, or customer orders. All numerical disclosure relates to patent identifiers and claim counts, which confirm progress in IP protection but do not evidence technical readiness or market demand. No data is provided on the status or likelihood of pending applications, nor is there any quantification of addressable markets or regulatory progress. The absence of financial or operational data precludes any assessment of business momentum or value realization.

Analysis

The announcement is primarily factual, reporting the receipt of three Notices of Allowance from the USPTO, which is a concrete milestone in intellectual property development. However, the company remains in the development stage and has not commenced commercial production, with no financial, operational, or profitability metrics disclosed. While the patent progress is real, the narrative includes forward-looking statements about intended applications, market impact, and future expansion of the IP portfolio, none of which are supported by measurable commercial or financial evidence. The language around reducing radioactive waste and enabling ultra-long-life clean-energy components is aspirational and not yet realised. There is no mention of large capital outlays or immediate earnings impact, so the capital intensity flag is not triggered. The gap between narrative and evidence is moderate: patent milestones are genuine, but commercial and financial outcomes remain speculative.

Risk flags

• ●There is no evidence of commercial traction, revenue, or customer agreements, which means the company remains entirely pre-revenue and pre-commercial. This matters because patent allowances alone do not guarantee technical feasibility, regulatory approval, or market adoption.
• ●The company’s forward-looking statements about reducing radioactive waste and enabling ultra-long-life clean-energy components are unsupported by any operational or demonstration data. This introduces execution risk, as there is no proof the technology can be manufactured or deployed at scale.
• ●All activities involving radioactive materials are subject to extensive regulation, including licensing by the U.S. Nuclear Regulatory Commission and state authorities. The announcement does not disclose any progress on obtaining these licenses, representing a significant regulatory hurdle before any commercial activity can commence.

Bottom line

This announcement signals real progress in securing U.S. patent protection for Nuclear Diamond Batteries, Inc., but offers no evidence of technical validation, regulatory progress, or commercial demand. The company is still pre-revenue and pre-production, with all value contingent on future development, licensing, and commercialization that remain unproven and undated. The narrative around market applications and environmental benefits is aspirational and not backed by operational or financial data. For investors, this update is not actionable as there is no pathway to near-term revenue or cash flow. The most important takeaway is that while the IP portfolio is expanding, the company’s business model and technology remain unproven, and substantial execution and regulatory risks persist. Only disclosure of technical milestones, regulatory licenses, or commercial contracts would make future announcements materially relevant for investment decisions.

Announcement summary

(OTC:NDBI) Nuclear Diamond Batteries, Inc. announced that as of July 2026, it has received three Notices of Allowance from the United States Patent and Trademark Office (USPTO) for its nuclear diamond battery architecture. The allowed patents include U.S. Patent Application No. 17/926,508 (issued as U.S. Patent No. 12,394,534 B2), U.S. Patent Application No. 17/928,967 (Notice of Allowance issued May 2026; 19 claims), and U.S. Patent Application No. 18/015,242 (Notice of Allowance issued July 7, 2026; 18 claims). The company’s patents and patent applications are held and managed through its majority-owned subsidiary AtomiQ, Inc. Additional patent applications related to semiconductor structures, isotope integration methods, and energy-optimization systems remain pending before the USPTO. The company is in the development stage and has not commenced commercial production. The handling, recycling, and encapsulation of radioactive materials are subject to extensive regulation, including licensing requirements of the U.S. Nuclear Regulatory Commission and/or applicable Agreement State authorities. The company projects further expansion of its intellectual property portfolio and plans to broaden geographic coverage and claim scope around key process, materials, and system-level innovations.

Disagree with this article?